Media Release

All Categories

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

10 October 2021

Blade Therapeutics Mourns the Passing of General Counsel and Secretary Alan C. Mendelson

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

02 June 2021

Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

30 November 2020

OneVentures Growth (Equity) Fund V combines capital and executional support to tech companies

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

06 October 2020

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

10 August 2020

Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

22 July 2020

OneVentures Venture Credit Fund poised to invest $120M into Australian scaleups

29 May 2020

Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate

28 May 2020

Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP)

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

19 May 2020

OneVentures expands team to internationalise its healthcare portfolio

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

17 March 2020

Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

16 March 2020

OneVentures invests in international software company Phocas, bringing business back to Australia and positioning the company for international expansion

15 January 2020

Pearson acquires interactive learning technology from Smart Sparrow

06 November 2019

iStaySafe Acquires Find-Me Technologies, Strengthens position in the IoT Industry

decor decor decor
decor decor decor decor decor
clear Close